AU2002213865A1 - Process for the racemisation of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahyd ropyridine to be used as intermediate in the synthesis of paroxetine - Google Patents

Process for the racemisation of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahyd ropyridine to be used as intermediate in the synthesis of paroxetine

Info

Publication number
AU2002213865A1
AU2002213865A1 AU2002213865A AU1386502A AU2002213865A1 AU 2002213865 A1 AU2002213865 A1 AU 2002213865A1 AU 2002213865 A AU2002213865 A AU 2002213865A AU 1386502 A AU1386502 A AU 1386502A AU 2002213865 A1 AU2002213865 A1 AU 2002213865A1
Authority
AU
Australia
Prior art keywords
paroxetine
fluorophenyl
hydroxymethyl
benzyl
racemisation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002213865A
Other languages
English (en)
Inventor
Jayne Froggett
Dean Riley
Andrew Turner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of AU2002213865A1 publication Critical patent/AU2002213865A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2002213865A 2000-08-30 2001-08-30 Process for the racemisation of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahyd ropyridine to be used as intermediate in the synthesis of paroxetine Abandoned AU2002213865A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0021147 2000-08-30
GBGB0021147.4A GB0021147D0 (en) 2000-08-30 2000-08-30 Chemical process
PCT/EP2001/009998 WO2002018338A1 (en) 2000-08-30 2001-08-30 Process for the racemisation of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetine

Publications (1)

Publication Number Publication Date
AU2002213865A1 true AU2002213865A1 (en) 2002-03-13

Family

ID=9898420

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002213865A Abandoned AU2002213865A1 (en) 2000-08-30 2001-08-30 Process for the racemisation of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahyd ropyridine to be used as intermediate in the synthesis of paroxetine

Country Status (16)

Country Link
US (1) US6949650B2 (https=)
EP (1) EP1315701B1 (https=)
JP (1) JP2004518620A (https=)
AT (1) ATE421953T1 (https=)
AU (1) AU2002213865A1 (https=)
CA (1) CA2420579C (https=)
CZ (1) CZ2003503A3 (https=)
DE (1) DE60137577D1 (https=)
ES (1) ES2320631T3 (https=)
GB (1) GB0021147D0 (https=)
HR (1) HRP20030227A2 (https=)
HU (1) HUP0302910A3 (https=)
IL (2) IL154302A0 (https=)
NO (1) NO324944B1 (https=)
SK (1) SK2342003A3 (https=)
WO (1) WO2002018338A1 (https=)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2748140A (en) * 1954-10-07 1956-05-29 Rohm & Haas 3-hydroxymethyl-4-phenyltetrahydro-pyridines and their esters
GB1422263A (en) 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
CN1068597C (zh) * 1995-05-17 2001-07-18 诺沃挪第克公司 制备4-芳基-哌啶衍生物的方法
GB9526645D0 (en) * 1995-12-28 1996-02-28 Chiroscience Ltd Stereoselective synthesis
HU221921B1 (hu) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
GB9710004D0 (en) 1997-05-17 1997-07-09 Knoll Ag Chemical process
DE19900576A1 (de) * 1999-01-09 2000-07-13 Merck Patent Gmbh Benzolderivate

Also Published As

Publication number Publication date
HUP0302910A3 (en) 2008-02-28
EP1315701A1 (en) 2003-06-04
IL154302A (en) 2008-11-03
GB0021147D0 (en) 2000-10-11
HRP20030227A2 (en) 2005-02-28
CA2420579A1 (en) 2002-03-07
NO324944B1 (no) 2008-01-07
WO2002018338A1 (en) 2002-03-07
EP1315701B1 (en) 2009-01-28
ES2320631T3 (es) 2009-05-27
IL154302A0 (en) 2003-09-17
US20040014786A1 (en) 2004-01-22
US6949650B2 (en) 2005-09-27
JP2004518620A (ja) 2004-06-24
CZ2003503A3 (cs) 2003-08-13
DE60137577D1 (de) 2009-03-19
HUP0302910A2 (hu) 2004-01-28
NO20030876L (no) 2003-02-25
SK2342003A3 (en) 2003-09-11
ATE421953T1 (de) 2009-02-15
NO20030876D0 (no) 2003-02-25
CA2420579C (en) 2009-11-03

Similar Documents

Publication Publication Date Title
MY111616A (en) Nover (r)-5-carbamoyl-8-fluoro-3-n, n-disubstituted-amino-3, 4-dihydro-2h-1-benzopyrans
UA100964C2 (ru) Способ получения кристаллических форм и кристаллические формы оптических энантиомеров модафинила
YU9802A (sh) Inhibitori ćelijske adhezije
WO2003070731A3 (en) Azabicyclic compounds for the treatment of disease
PL1756052T3 (pl) Ulepszony sposób wytwarzania związków 3-hydroksy-4-hydroksymetylopirolidynowych
MX9806209A (es) Proceso para la preparacion de d-treo-(r,r)-metil fenidato y recirculacion de enantiomeros no deseados a traves de epimerizacion.
SE0203303D0 (sv) Novel Compounds
HU9802586D0 (en) Racemizing process
CA2431400A1 (en) Process for preparing isomers of salbutamol
SI1525188T1 (sl) Novi derivati 4,4-ditiobis-(3-aminobutan-1-sulfonatov) in sestavki, ki jih vsebujejo
CA2455042A1 (en) Method of reducing hair growth by applying alpha-difluoromethylornithine
AU2002213865A1 (en) Process for the racemisation of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahyd ropyridine to be used as intermediate in the synthesis of paroxetine
AU7624398A (en) New substituted tetrahydropyridine compounds, process for preparing them and pharmaceutical compositions containing them
WO2005037780A3 (de) Amidomethyl-substituierte 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h-chromen-6-yl-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
ATE127465T1 (de) Isoindolinon-derivat, seine herstellung und dieses enthaltende pharmazeutische zusammen setzungen.
CA2320756A1 (en) Process for the production of optically enriched (r)- or (s)-albuterol
MX9708612A (es) Derivados de alfa-(alquilfenilo sustituido)-4-(hidroxidifenilmetil)-1-piperidinbutanol, su preparacion y su uso como antihistaminas, agentes antialergicos, y broncodilatadores.
BR9608237A (pt) Processos para preparar 1-(piridil)-2-cicloexiletilamina racêmica e anantiomérica.
IL156768A0 (en) Process for preparing (+/-) trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine
YU1500A (sh) Postupak za dobijanje aminskih derivata alkiloksifuranona, dobijena jedinjenja i korišćenje ovih jedinjenja
MXPA05009053A (es) Metodo para producir las formas enantiomericas de derivados de 1,3-ciclohexanodiol en configuracion cis.
BR0008586A (pt) Processo de preparação de aminoácidos quirais e processo de preparação de compostos a partir destes
GEP20084296B (en) Novel 3-(4-oxo-4h-chromen-2-yl)-(1h)-quinoline-4-one derivatives, method for preparing same and pharmaceutical compositions containing same
MY117689A (en) A new process for the preparation of 3-n, n-dicycobutylamino-8-fluoro-3, 4-dihydro-2h-1-benzopyran-5-carboxamide
NO20016390L (no) Fremgangsmåte for fremstilling av (-)-(1S,4R) N-beskyttede 4- amino-2-cyklopenten-1-karboksylatestere